March 2022 - Page 6 of 32

MondayMar 28, 2022 9:00 am

Delic Holdings Corp’s (CSE: DELC) (OTCQB: DELCF) Co-Founder and CEO Offers a Glimpse into the Company’s History and Future on The Jesse Tee Show

While appearing on The Jesse Tee Show, the company’s co-founder and CEO, Matt Stang, shared his professional background, Delic’s history, its growth, and its plans going forward Mr. Stang attributes its success to understanding where opportunities and people connect, how to make things win-win for all people, and giving customers value Founded in 2016, Delic Holdings Corp now has a market cap of $4.32 million as of March 2022 Delic Holdings (CSE: DELC) (OTCQB: DELCF) has been at the forefront of reframing the psychedelic conversation. It has also remained committed to bringing science-backed benefits of psychedelics to the health industry,…

MondayMar 28, 2022 9:00 am

Autonomous Security Robot Developer Knightscope Inc. (NASDAQ: KSCP) Explains IP Advantage as Nasdaq Listing Gains Attention

Artificial intelligence-enhanced security devices and big data collection are gaining popularity as means for strengthening companies’ footprints, particularly in response to criminal activity that can otherwise weaken operations Knightscope is a Silicon Valley-based company developing Autonomous Security Robots (“ASRs”) in response to America’s security needs, delivering a variety of models that observe and report on activity at client properties using powerful technological services Knightscope completed public listing on the Nasdaq Exchange in January 2022, enhancing awareness of its products and generating new inquiries about the nature of its services The company has taken note of its successes with its clients,…

MondayMar 28, 2022 9:00 am

Psychedelic Medicine Researcher Mydecine Innovations Group Inc. (NEO: MYCO) (OTC: MYCOF) (FSE: 0NFA) Readies IND Application to Advance Drug Trials

Novel drug development company Mydecine Innovations Group is focusing on a medicinal pipeline for psychedelic drug candidates that have established some efficacy in treating mental illnesses — specifically addiction Mydecine is progressing in its clinical trial evaluation of its lead candidate, MYCO-001, and is finalizing an IND application with the FDA to begin patient dosing for its planned Phase 2 trials The company is targeting nicotine addiction in tobacco smokers Mydecine is also advancing its evaluation of other drug candidates with pending patents to enhance its existing products Medical-use psychedelic drug product developer Mydecine Innovations Group (NEO: MYCO) (OTC: MYCOF)…

FridayMar 25, 2022 3:50 pm

QualityStocksNewsBreaks – Nowigence Inc.’s Pluaris Enables Team Collaboration, Real-Time Sharing from Anywhere in the World

Nowigence has developed an off-the-shelf, cloud-based artificial intelligence (“AI”) platform called Pluaris(TM), designed specifically to help hobby readers, students and professionals (journalists, authors, researchers, and analysts) handle and organize the mass of material available. A recent article explains: “When the amount of material that readers want or need to process exceeds their capacity, several things can happen, including fatigue, inability to concentrate, or problems recalling information. It is precisely these problems that Pluaris is designed to solve. ‘Pluaris mimics the way that we, as humans, read, analyze and comprehend textual data,’ the company states.” Pluaris can analyze hundreds of pages…

FridayMar 25, 2022 3:40 pm

QualityStocksNewsBreaks – Lexaria Bioscience Corp. (NASDAQ: LEXX) Optimistic About Its Upcoming, Largest-Ever Hypertension Study

Lexaria Bioscience Corp. (NASDAQ: LEXX) remains committed to enhancing the speed and efficiency of orally-delivered fat-soluble active molecules and drugs. “Through its patented DehydraTECH(TM) drug delivery technology that began development in 2014, the company is offering potential solutions for conditions including, but not limited to hypertension, smoking cessation, anti-viral treatments, and other drug classes,” reads a recent article. The piece discusses significant developments Lexaria has made with its HYPER-H21-4 clinical study on hypertension and heart disease treatment using DehydraTECH-CBD. Given the success of previous studies, the company announced plans for more trials over 2022. “During 2021, we completed research &…

FridayMar 25, 2022 3:25 pm

QualityStocksNewsBreaks – Tingo Inc. (TMNA) Committed to Uniting Commercial Success with Shared Prosperity

Tingo (OTC: TMNA) is eyeing a potential expansion beyond its domestic market – Nigeria – to elevate opportunities for rural communities across Africa. Tingo is poised to grow into a truly pan-African company and is seeking to increase its market footprint across 19 countries on the continent. “Uncompromised in its commitment to uniting commercial success with shared prosperity, Tingo doubles down on its efforts to become a truly global company, one built from the ground up within Africa… In its 21-year long journey, Tingo has always been focused on delivering value beyond commercial success. What started as an entrepreneurial endeavor…

FridayMar 25, 2022 3:12 pm

QualityStocksNewsBreaks – StraightUp Resources Inc. (CSE: ST) (OTCQB: STUPF) Focused on Executing 2022 Plans, Including New Acquisitions, Expanded Market Reach

StraightUp Resources (CSE: ST) (OTCQB: STUPF) recognizes the issues posed by the Ukraine crisis, which, though focused on Eastern Europe, is affecting various sectors globally. “Despite its properties being located in North America, the developments in Russia and Ukraine, coupled with the former’s sanctions, are affecting its operations and its shareholders’ willingness to take more investment risks,” a recent article reads. “Following the conflict, the price of gold and other precious metals has surged. Palladium, for instance, has seen a 5.1% increase in value for the third consecutive month, while gold has risen by 6.5%, reaching an 18-month high of…

FridayMar 25, 2022 3:00 pm

QualityStocksNewsBreaks – SRAX Inc. (NASDAQ: SRAX) Bringing Crisp, Precise Data Delivery, Power of Big Data Analytics

SRAX (NASDAQ: SRAX), a financial technology company that unlocks data and insights for publicly traded companies through Sequire, its software-as-a-service (“SaaS”) platform, has developed and acquired a portfolio of products that maximizes engagement for durable corporate and brand awareness while delivering transparent insight into companies for investors to perform due diligence. SRAX is bringing crisp, precise data delivery that provides clarity in a matter of minutes with an opportunity for a deeper dive and is using the power of big data to back it up. “SRAX takes a holistic approach to the investor space with its Sequire platform, beginning by…

FridayMar 25, 2022 2:30 pm

The Virtual Growth Conference By M-Vest Events to Offer a Powerful Networking Stage

Fintech, Healthcare, pharma, technology, finance, infrastructure, and allied companies and investors are invited to attend the Virtual Growth Conference, being held on March 28-30, 2022, as a virtual event. The year 2022 opens up opportunities for traders and investors and this Virtual Growth Conference 2022 offers the perfect stage for networking and understanding the future scope of business. The Virtual Growth Conference is one of the leading investor conferences, organized by M-Vest Events, powered by the Maxim Group LLC, a leading investment bank. The group serves investors, issuers and industry stalwarts, allowing them to interact on an excellent online forum.…

FridayMar 25, 2022 2:18 pm

QualityStocksNewsBreaks – InMed Pharmaceuticals Inc. (NASDAQ: INM) Committed to Execute More Programs to Grow Market Reach and Product Portfolio

InMed Pharmaceuticals (NASDAQ: INM) President and CEO Eric A. Adams recently hosted a conference call and webcast in which he emphasized the company’s successful product diversification and strategic acquisition achievements. He expressed his optimism at the company’s expansion into the health and wellness sector as an ingredient supplier and the integration of BayMedica’s operations and team into its ongoing activities. A recent article reads: “While noting how recent product launches have allowed the company to top its revenue estimates, Mr. Adams was also keen to point out its ongoing commitment to launch even more products in the coming months. He…

Site Search

Company Search

Month: March 2022

Delic Holdings Corp’s (CSE: DELC) (OTCQB: DELCF) Co-Founder and CEO Offers a Glimpse into the Company’s History and Future on The Jesse Tee Show

Autonomous Security Robot Developer Knightscope Inc. (NASDAQ: KSCP) Explains IP Advantage as Nasdaq Listing Gains Attention

Psychedelic Medicine Researcher Mydecine Innovations Group Inc. (NEO: MYCO) (OTC: MYCOF) (FSE: 0NFA) Readies IND Application to Advance Drug Trials

QualityStocksNewsBreaks – Nowigence Inc.’s Pluaris Enables Team Collaboration, Real-Time Sharing from Anywhere in the World

QualityStocksNewsBreaks – Lexaria Bioscience Corp. (NASDAQ: LEXX) Optimistic About Its Upcoming, Largest-Ever Hypertension Study

QualityStocksNewsBreaks – Tingo Inc. (TMNA) Committed to Uniting Commercial Success with Shared Prosperity

QualityStocksNewsBreaks – StraightUp Resources Inc. (CSE: ST) (OTCQB: STUPF) Focused on Executing 2022 Plans, Including New Acquisitions, Expanded Market Reach

QualityStocksNewsBreaks – SRAX Inc. (NASDAQ: SRAX) Bringing Crisp, Precise Data Delivery, Power of Big Data Analytics

The Virtual Growth Conference By M-Vest Events to Offer a Powerful Networking Stage

QualityStocksNewsBreaks – InMed Pharmaceuticals Inc. (NASDAQ: INM) Committed to Execute More Programs to Grow Market Reach and Product Portfolio

Market Basics

Newsletter Publishers

Public Companies